Loading...

Pulmonary large cell carcinoma, highly positive for PD‐L1, shows marked response to pembrolizumab: A case report

Pulmonary large cell carcinoma (LCC) is classified as a poorly defined entity among non‐small cell lung cancers (NSCLCs). At present, there are no effective anticancer drugs, such as molecular targeted drugs, for LCC, and it has been reported that patient prognosis is poor. Recently, the development...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Okabe, Naoyuki, Mine, Hayato, Takagi, Hironori, Watanabe, Masayuki, Muto, Satoshi, Matsumura, Yuki, Shio, Yutaka, Suzuki, Hiroyuki
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons Australia, Ltd 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017242/
https://ncbi.nlm.nih.gov/pubmed/33605014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13850
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!